Evaluation of SARS-CoV‑2 Main Protease Inhibitors Using a Novel Cell-Based Assay
Main Authors: | Wenyue Cao, Chia-Chuan Dean Cho, Zhi Zachary Geng, Namir Shaabani, Xinyu R. Ma, Erol C. Vatansever, Yugendar R. Alugubelli, Yuying Ma, Sankar P. Chaki, William H. Ellenburg, Kai S. Yang, Yuchen Qiao, Robert Allen, Benjamin W. Neuman, Henry Ji, Shiqing Xu, Wenshe Ray Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2022-02-01
|
Series: | ACS Central Science |
Online Access: | https://doi.org/10.1021/acscentsci.1c00910 |
Similar Items
-
Accurate Mass Identification of an Interfering Water Adduct and Strategies in Development and Validation of an LC-MS/MS Method for Quantification of MPI8, a Potent SARS-CoV-2 Main Protease Inhibitor, in Rat Plasma in Pharmacokinetic Studies
by: Yang Wang, et al.
Published: (2022-05-01) -
Site-Specific Conversion of Cysteine in a Protein to Dehydroalanine Using 2-Nitro-5-thiocyanatobenzoic Acid
by: Yuchen Qiao, et al.
Published: (2021-04-01) -
Validating the inactivation of viral pathogens with a focus on SARS-CoV-2 to safely transfer samples from high-containment laboratories
by: Sankar Prasad Chaki, et al.
Published: (2024-03-01) -
Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants
by: Sankar Prasad Chaki, et al.
Published: (2022-06-01) -
Analysis of Crowd Flow Parameters Using Artificial Neural Network
by: Yugendar Poojari, et al.
Published: (2018-12-01)